Case: NOVUS partners with university to safely store the vaccine against COVID-19

Posted on by

Last week, Rio Grande do Sul (state of Brazil) received the first batch of 32,760 doses of COVID-19 vaccines from Pfizer/BioNTech. This immunizer must be kept at a temperature of -70 °C (-94 °F), so it will be stored in ultrapotent freezers provided by the Federal University of Rio Grande do Sul (UFRGS).

In partnership with UFRGS, JMD, NOVUS‘ exclusive representative in Rio Grande do Sul, has developed a project to monitor up to 88 ultrapotent freezers.

This solution has FieldLogger data loggers, DigiRail VA signal transmitters, Pt100 temperature sensors (-100 °C / -148 °F), as well as 24Vdc power supplies and industrial no-breaks. NOVUS performed the ILAC calibration of all devices. JMD was responsible for assembling and installing the project, as well as training the staff of the Institute of Basic Health Sciences, the University agency responsible for the ultrapotent freezers.

JMD also installed systems to monitor the vaccines against COVID in the hospitals of the Conceição Hospital Group, which have teams to fight the virus.

At this first moment, for logistics and conservation reasons, Pfizer/BioNTech vaccines will be used only in the city of Porto Alegre (capital of Rio Grande do Sul). Its goal is to complete the elderly group and the phase 1 vaccination of people with comorbidities.

Once again, NOVUS’ technology contributes to the healthcare and to the fight against this terrible disease, which has already claimed more than 400 thousand victims in Brazil alone.